Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | EMC7 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | ZNF443 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | RUFY3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | TAPT1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | RBM12B | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | KLHDC3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |